| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-73454 |
Vicasinabin
|
1433361-02-4 |
Vicasinabin (RG7774, RG-7774) is a potent, selective agonist of cannabinoid receptor 2 (CB2) with cAMP EC50 of 1 nM (hCB2), >800-fold selectivity over CB1 receptor. |
| PC-43210 |
CB1-IN-4
|
1429239-98-4 |
DBPR211 (BPRCB1184, CB1-IN-4) is a potent, selective, peripherally restricted cannabinoid-1 (CB1) receptor antagonist with Ki of 0.3 nM, EC50 of 3.0 nM. |
| PC-60146 |
APD-371
|
1268881-20-4 |
APD-371 (APD371, Olorinab) is a potent, selective and orally available CB2 agonist with EC50 of 6.2 nM. |
| PC-60086 |
AM-6538
|
1245626-00-9 |
AM-6538 (AM6538) is a potent, selective cannabinoid receptor CB1 antagonist with Ki of 5.1 nM.. |
| PC-20170 |
MRI-1891
|
2712480-46-9 |
MRI-1891 (MRI 1891) is potent, selective, β-Arrestin-2-biased peripheral cannabinoid-1 receptor (CB1R) antagonist with Ki of 0.3 nM (hCB1R), >2000-fold CB1R/CB2R selectivity. |
| PC-20082 |
AM251
|
183232-66-8 |
AM251 (AM 251) is a potent, selective CB1 receptor antagonist (inverse agonist) with IC50 of 8 nM, Ki of 7.49 nM, displays 306-fold selectivity over CB2 receptors. |
| PC-20078 |
URB447
|
1132922-57-6 |
URB447 (URB-447) is a peripherally restricted CB(1) antagonist/CB(2) agonist with IC50 of 313 nM (rat CB1) and 41 nM (human CB2). |
